La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
CardieX Croissance future
Future contrôle des critères 5/6
CardieX is forecast to grow earnings and revenue by 115.9% and 61.6% per annum respectively while EPS is expected to grow by 122.1% per annum.
Informations clés
115.9%
Taux de croissance des bénéfices
122.1%
Taux de croissance du BPA
Medical Equipment croissance des bénéfices | 16.0% |
Taux de croissance des recettes | 61.6% |
Rendement futur des capitaux propres | n/a |
Couverture par les analystes | Low |
Dernière mise à jour | 06 Aug 2024 |
Mises à jour récentes de la croissance future
Pas de mise à jour
Prévisions de croissance des bénéfices et des revenus
Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
---|---|---|---|---|---|
6/30/2026 | 52 | 24 | 24 | 24 | 1 |
6/30/2025 | 18 | -3 | -3 | -3 | 1 |
6/30/2024 | 12 | -8 | -11 | -11 | 1 |
12/31/2023 | 14 | -9 | -5 | -5 | N/A |
9/30/2023 | 10 | -14 | -9 | -9 | N/A |
6/30/2023 | 6 | -19 | -12 | -12 | N/A |
3/31/2023 | 5 | -16 | -11 | -11 | N/A |
12/31/2022 | 4 | -14 | -10 | -10 | N/A |
9/30/2022 | 4 | -13 | -10 | -9 | N/A |
6/30/2022 | 5 | -12 | -10 | -9 | N/A |
3/31/2022 | 5 | -11 | -9 | -8 | N/A |
12/31/2021 | 5 | -10 | -8 | -8 | N/A |
9/30/2021 | 5 | -7 | -6 | -6 | N/A |
6/30/2021 | 6 | -5 | -4 | -4 | N/A |
3/31/2021 | 5 | -4 | -3 | -3 | N/A |
12/31/2020 | 5 | -3 | -2 | -2 | N/A |
9/30/2020 | 5 | -3 | -2 | -2 | N/A |
6/30/2020 | 5 | -3 | -2 | -2 | N/A |
3/31/2020 | 5 | -3 | -2 | -2 | N/A |
12/31/2019 | 5 | -4 | -2 | -2 | N/A |
9/30/2019 | 5 | -3 | -2 | -2 | N/A |
6/30/2019 | 5 | -3 | -3 | -2 | N/A |
3/31/2019 | 5 | -3 | -3 | -3 | N/A |
12/31/2018 | 4 | -3 | -3 | -3 | N/A |
9/30/2018 | 4 | -3 | -2 | -2 | N/A |
6/30/2018 | 4 | -3 | -2 | -2 | N/A |
3/31/2018 | 5 | -3 | -2 | -2 | N/A |
12/31/2017 | 5 | -4 | -2 | -2 | N/A |
9/30/2017 | 5 | -4 | N/A | -3 | N/A |
6/30/2017 | 5 | -4 | N/A | -3 | N/A |
3/31/2017 | 5 | -4 | N/A | -4 | N/A |
12/31/2016 | 5 | -4 | N/A | -4 | N/A |
9/30/2016 | 5 | -5 | N/A | -5 | N/A |
6/30/2016 | 5 | -5 | N/A | -5 | N/A |
3/31/2016 | 5 | -4 | N/A | -4 | N/A |
12/31/2015 | 4 | -4 | N/A | -4 | N/A |
9/30/2015 | 5 | -3 | N/A | -3 | N/A |
6/30/2015 | 5 | -1 | N/A | -2 | N/A |
3/31/2015 | 5 | -2 | N/A | -2 | N/A |
12/31/2014 | 5 | -2 | N/A | -3 | N/A |
9/30/2014 | 5 | -2 | N/A | -2 | N/A |
6/30/2014 | 5 | -3 | N/A | -1 | N/A |
3/31/2014 | 6 | -2 | N/A | 0 | N/A |
12/31/2013 | 6 | 0 | N/A | 1 | N/A |
9/30/2013 | 8 | 1 | N/A | 1 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: CDX is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.4%).
Bénéfices vs marché: CDX is forecast to become profitable over the next 3 years, which is considered above average market growth.
Croissance élevée des bénéfices: CDX is expected to become profitable in the next 3 years.
Chiffre d'affaires vs marché: CDX's revenue (61.6% per year) is forecast to grow faster than the Australian market (5.4% per year).
Croissance élevée des revenus: CDX's revenue (61.6% per year) is forecast to grow faster than 20% per year.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Insufficient data to determine if CDX's Return on Equity is forecast to be high in 3 years time